Download Zipped Enrolled WP 8.0 HB0139.ZIP 18,746 Bytes
[Introduced][Amended][Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 139 Enrolled

                 

UTAH CONTROLLED SUBSTANCES ACT AMENDMENTS

                 
2000 GENERAL SESSION

                 
STATE OF UTAH

                 
Sponsor: Patrice M. Arent

                  AN ACT RELATING TO CONTROLLED SUBSTANCES; AMENDING THE SCHEDULES
                  OF SUBSTANCES TO REFLECT FEDERAL CHANGES; AND PROVIDING AN EFFECTIVE
                  DATE.
                  This act affects sections of Utah Code Annotated 1953 as follows:
                  AMENDS:
                      58-37-4, as last amended by Chapter 283, Laws of Utah 1998
                  This act enacts uncodified material.
                  Be it enacted by the Legislature of the state of Utah:
                      Section 1. Section 58-37-4 is amended to read:
                       58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
                  required -- Specific substances included in schedules.
                      (1) There are established five schedules of controlled substances known as Schedules I, II,
                  III, IV, and V which shall consist of substances listed in this section.
                      (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by the
                  official name, common or usual name, chemical name, or brand name designated:
                      (a) Schedule I:
                      (i) Unless specifically excepted or unless listed in another schedule, any of the following
                  opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when
                  the existence of the isomers, esters, ethers, and salts is possible within the specific chemical
                  designation:
                      (A) Acetyl-alpha-methylfentanyl
                  (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
                      (B) Acetylmethadol;
                      (C) Allylprodine;
                      (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as


                  levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
                      (E) Alphameprodine;
                      (F) Alphamethadol;
                      (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide;
                  1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine);
                      (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
                  piperidinyl]-N-phenylpropanamide);
                      (I) Benzethidine;
                      (J) Betacetylmethadol;
                      (K) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
                  piperidinyl]-N-phenylpropanamide);
                      (L) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
                  phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
                      (M) Betameprodine;
                      (N) Betamethadol;
                      (O) Betaprodine;
                      (P) Clonitazene;
                      (Q) Dextromoramide;
                      (R) Diampromide;
                      (S) Diethylthiambutene;
                      (T) Difenoxin;
                      (U) Dimenoxadol;
                      (V) Dimepheptanol;
                      (W) Dimethylthiambutene;
                      (X) Dioxaphetyl butyrate;
                      (Y) Dipipanone;
                      (Z) Ethylmethylthiambutene;
                      (AA) Etonitazene;

- 2 -


                      (BB) Etoxeridine;
                      (CC) Furethidine;
                      (DD) Hydroxypethidine;
                      (EE) Ketobemidone;
                      (FF) Levomoramide;
                      (GG) Levophenacylmorphan;
                      (HH) Morpheridine;
                      (II) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
                      (JJ) Noracymethadol;
                      (KK) Norlevorphanol;
                      (LL) Normethadone;
                      (MM) Norpipanone;
                      (NN) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
                  propanamide;
                      (OO) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
                      (PP) Phenadoxone;
                      (QQ) Phenampromide;
                      (RR) Phenomorphan;
                      (SS) Phenoperidine;
                      (TT) Piritramide;
                      (UU) Proheptazine;
                      (VV) Properidine;
                      (WW) Propiram;
                      (XX) Racemoramide;
                      (YY) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
                      (ZZ) Tilidine;
                      (AAA) Trimeperidine;
                      (BBB) 3-methylfentanyl, including the optical and geometric isomers

- 3 -


                  (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
                      (CCC) 3-methylthiofentanyl
                  (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
                      (ii) Unless specifically excepted or unless listed in another schedule, any of the following
                  opium derivatives, their salts, isomers, and salts of isomers when the existence of the salts, isomers,
                  and salts of isomers is possible within the specific chemical designation:
                      (A) Acetorphine;
                      (B) Acetyldihydrocodeine;
                      (C) Benzylmorphine;
                      (D) Codeine methylbromide;
                      (E) Codeine-N-Oxide;
                      (F) Cyprenorphine;
                      (G) Desomorphine;
                      (H) Dihydromorphine;
                      (I) Drotebanol;
                      (J) Etorphine (except hydrochloride salt);
                      (K) Heroin;
                      (L) Hydromorphinol;
                      (M) Methyldesorphine;
                      (N) Methylhydromorphine;
                      (O) Morphine methylbromide;
                      (P) Morphine methylsulfonate;
                      (Q) Morphine-N-Oxide;
                      (R) Myrophine;
                      (S) Nicocodeine;
                      (T) Nicomorphine;
                      (U) Normorphine;
                      (V) Pholcodine; and

- 4 -


                      (W) Thebacon.
                      (iii) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of the following hallucinogenic substances, or
                  which contains any of their salts, isomers, and salts of isomers when the existence of the salts,
                  isomers, and salts of isomers is possible within the specific chemical designation; as used in this
                  Subsection (2)(iii) only, "isomer" includes the optical, position, and geometric isomers:
                      (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
                  .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
                      (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
                  4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
                      (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
                  2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
                      (D) 2,5-dimethoxyamphetamine, some trade or other names:
                  2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
                      (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
                      (F) 4-methoxyamphetamine, some trade or other names: 4-methoxy-.-methylphenethylamine;
                  paramethoxyamphetamine, PMA;
                      (G) 5-methoxy-3,4-methylenedioxyamphetamine;
                      (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
                  4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
                      (I) 3,4-methylenedioxy amphetamine;
                      (J) 3,4-methylenedioxymethamphetamine (MDMA);
                      (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
                  alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
                      (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
                  N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
                      (M) 3,4,5-trimethoxy amphetamine;
                      (N) Bufotenine, some trade and other names: 3-(. -Dimethylaminoethyl)-5-hydroxyindole;

- 5 -


                  3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine;
                  mappine;
                      (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
                      (P) Dimethyltryptamine, some trade or other names: DMT;
                      (Q) Ibogaine, some trade and other names:
                  7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
                  [5,4-b] indole; Tabernanthe iboga;
                      (R) Lysergic acid diethylamide;
                      (S) Marijuana;
                      (T) Mescaline;
                      (U) Parahexyl, some trade or other names:
                  3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
                      (V) Peyote, meaning all parts of the plant presently classified botanically as Lophophora
                  williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such
                  plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its
                  seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
                      (W) N-ethyl-3-piperidyl benzilate;
                      (X) N-methyl-3-piperidyl benzilate;
                      (Y) Psilocybin;
                      (Z) Psilocyn;
                      (AA) Tetrahydrocannabinols, synthetic equivalents of the substances contained in the plant,
                  or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their
                  isomers with similar chemical structure and pharmacological activity such as the following: .1 cis or
                  trans tetrahydrocannabinol, and their optical isomers .6 cis or trans tetrahydrocannabinol, and their
                  optical isomers .3,4 cis or trans tetrahydrocannabinol, and its optical isomers, and since
                  nomenclature of these substances is not internationally standardized, compounds of these structures,
                  regardless of numerical designation of atomic positions covered;
                      (BB) Ethylamine analog of phencyclidine, some trade or other names:

- 6 -


                  N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
                  N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
                      (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
                  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
                      (DD) Thiophene analog of phencyclidine, some trade or other names:
                  1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
                      (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
                      (iv) Unless specifically excepted or unless listed in another schedule, any material compound,
                  mixture, or preparation which contains any quantity of the following substances having a depressant
                  effect on the central nervous system, including its salts, isomers, and salts of isomers when the
                  existence of the salts, isomers, and salts of isomers is possible within the specific chemical
                  designation:
                      (A) Mecloqualone; and
                      (B) Methaqualone.
                      (v) Any material, compound, mixture, or preparation containing any quantity of the following
                  substances having a stimulant effect on the central nervous system, including their salts, isomers, and
                  salts of isomers:
                      (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
                  4,5-dihydro-5-phenyl-2-oxazolamine;
                      (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
                  alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
                      (C) Fenethylline;
                      (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
                  alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
                  alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
                  methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
                  optical isomers;
                      (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);

- 7 -


                      (F) N-ethylamphetamine; and
                      (G) N,N-dimethylamphetamine, also known as N,N-alpha-trimethyl-benzeneethanamine;
                  N,N-alpha-trimethylphenethylamine.
                      (vi) Any material, compound, mixture, or preparation which contains any quantity of the
                  following substances, including their optical isomers, salts, and salts of isomers, subject to temporary
                  emergency scheduling:
                      (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
                      (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
                      (b) Schedule II:
                      (i) Unless specifically excepted or unless listed in another schedule, any of the following
                  substances whether produced directly or indirectly by extraction from substances of vegetable origin,
                  or independently by means of chemical synthesis, or by a combination of extraction and chemical
                  synthesis:
                      (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate,
                  excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their
                  respective salts, but including:
                      (I) Raw opium;
                      (II) Opium extracts;
                      (III) Opium fluid;
                      (IV) Powdered opium;
                      (V) Granulated opium;
                      (VI) Tincture of opium;
                      (VII) Codeine;
                      (VIII) Ethylmorphine;
                      (IX) Etorphine hydrochloride;
                      (X) Hydrocodone;
                      (XI) Hydromorphone;
                      (XII) Metopon;

- 8 -


                      (XIII) Morphine;
                      (XIV) Oxycodone;
                      (XV) Oxymorphone; and
                      (XVI) Thebaine;
                      (B) Any salt, compound, derivative, or preparation which is chemically equivalent or identical
                  with any of the substances referred to in Subsection (2)(b)(i)(A), except that these substances may
                  not include the isoquinoline alkaloids of opium;
                      (C) Opium poppy and poppy straw;
                      (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any
                  salt, compound, derivative, or preparation which is chemically equivalent or identical with any of
                  these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives, and salts of
                  isomers and derivatives, whether derived from the coca plant or synthetically produced, except the
                  substances may not include decocainized coca leaves or extraction of coca leaves, which extractions
                  do not contain cocaine or ecgonine; and
                      (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
                  liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
                      (ii) Unless specifically excepted or unless listed in another schedule, any of the following
                  opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when the
                  existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation,
                  except dextrorphan and levopropoxyphene:
                      (A) Alfentanil;
                      (B) Alphaprodine;
                      (C) Anileridine;
                      (D) Bezitramide;
                      (E) Bulk dextropropoxyphene (nondosage forms);
                      (F) Carfentanil;
                      (G) Dihydrocodeine;
                      (H) Diphenoxylate;

- 9 -


                      (I) Fentanyl;
                      (J) Isomethadone;
                      (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol, levomethadyl
                  acetate, or LAAM;
                      (L) Levomethorphan;
                      (M) Levorphanol;
                      (N) Metazocine;
                      (O) Methadone;
                      (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
                      (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;
                      (R) Pethidine (meperidine);
                      (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
                      (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
                      (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
                      (V) Phenazocine;
                      (W) Piminodine;
                      (X) Racemethorphan;
                      (Y) Racemorphan;
                      (Z) Remifentanil; and
                      (AA) Sufentanil.
                      (iii) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of the following substances having a stimulant
                  effect on the central nervous system:
                      (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
                      (B) Methamphetamine, its salts, isomers, and salts of its isomers;
                      (C) Phenmetrazine and its salts; and
                      (D) Methylphenidate.
                      (iv) Unless specifically excepted or unless listed in another schedule, any material, compound,

- 10 -


                  mixture, or preparation which contains any quantity of the following substances having a depressant
                  effect on the central nervous system, including its salts, isomers, and salts of isomers when the
                  existence of the salts, isomers, and salts of isomers is possible within the specific chemical
                  designation:
                      (A) Amobarbital;
                      (B) Glutethimide;
                      (C) Pentobarbital;
                      (D) Phencyclidine;
                      (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
                  1-piperidinocyclohexanecarbonitrile (PCC); and
                      (F) Secobarbital.
                      (v) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of Phenylacetone.
                      Some of these substances may be known by trade or other names: phenyl-2-propanone, P2P;
                  benzyl methyl ketone, methyl benzyl ketone.
                      [(vi) (A) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
                  U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
                  (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
                  (-)-delta-9-(trans)-tetrahydrocannabinol; and]
                      [(B)] (vi) Nabilone, another name for nabilone:
                  (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
                  6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
                      (c) Schedule III:
                      (i) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of the following substances having a stimulant
                  effect on the central nervous system, including its salts, isomers whether optical, position, or
                  geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is
                  possible within the specific chemical designation:

- 11 -


                      (A) Those compounds, mixtures, or preparations in dosage unit form containing any
                  stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were listed
                  on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the Code of
                  Federal Regulations, and any other drug of the quantitive composition shown in that list for those
                  drugs or which is the same except that it contains a lesser quantity of controlled substances;
                      (B) Benzphetamine;
                      (C) Chlorphentermine;
                      (D) Clortermine; and
                      (E) Phendimetrazine.
                      (ii) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of the following substances having a depressant
                  effect on the central nervous system:
                      (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
                  pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients which
                  are not listed in any schedule;
                      (B) Any suppository dosage form containing amobarbital, secobarbital, or pentobarbital, or
                  any salt of any of these drugs which is approved by the Food and Drug Administration for marketing
                  only as a suppository;
                      (C) Any substance which contains any quantity of a derivative of barbituric acid or any salt
                  of any of them;
                      (D) Chlorhexadol;
                      (E) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine: .
                  -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone.
                      [(E)] (F) Lysergic acid;
                      [(F)] (G) Lysergic acid amide;
                      [(G)] (H) Methyprylon;
                      [(H)] (I) Sulfondiethylmethane;
                      [(I)] (J) Sulfonethylmethane;

- 12 -


                      [(J)] (K) Sulfonmethane; and
                      [(K)] (L) Tiletamine and zolazepam or any of their salts, some trade or other names for a
                  tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
                  2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
                  4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
                  flupyrazapon.
                      (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S.
                  Food and Drug Administration approved drug product, some other names for dronabinol:
                  (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
                  (-)-delta-9-(trans)-tetrahydrocannabinol.
                      [(iii)] (iv) Nalorphine.
                      [(iv)] (v) Unless specifically excepted or unless listed in another schedule, any material,
                  compound, mixture, or preparation containing limited quantities of any of the following narcotic
                  drugs, or their salts calculated as the free anhydrous base or alkaloid:
                      (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams
                  per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
                      (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams
                  per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts;
                      (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than
                  15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of
                  opium;
                      (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than
                  15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized
                  therapeutic amounts;
                      (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
                  milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
                  therapeutic amounts;
                      (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15

- 13 -


                  milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized
                  therapeutic amounts;
                      (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more
                  than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized
                  therapeutic amounts;
                      (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one
                  or more active, non-narcotic ingredients in recognized therapeutic amounts.
                      (v) Unless specifically excepted or unless listed in another schedule, anabolic steroids
                  including any of the following or any isomer, ester, salt, or derivative of the following that promotes
                  muscle growth:
                      (A) Boldenone;
                      (B) Chlorotestosterone (4-chlortestosterone);
                      (C) Clostebol;
                      (D) Dehydrochlormethyltestosterone;
                      (E) Dihydrotestosterone (4-dihydrotestosterone);
                      (F) Drostanolone;
                      (G) Ethylestrenol;
                      (H) Fluoxymesterone;
                      (I) Formebulone (formebolone);
                      (J) Mesterolone;
                      (K) Methandienone;
                      (L) Methandranone;
                      (M) Methandriol;
                      (N) Methandrostenolone;
                      (O) Methenolone;
                      (P) Methyltestosterone;
                      (Q) Mibolerone;
                      (R) Nandrolone;

- 14 -


                      (S) Norethandrolone;
                      (T) Oxandrolone;
                      (U) Oxymesterone;
                      (V) Oxymetholone;
                      (W) Stanolone;
                      (X) Stanozolol;
                      (Y) Testolactone;
                      (Z) Testosterone; and
                      (AA) Trenbolone.
                      Anabolic steroids expressly intended for administration through implants to cattle or other
                  nonhuman species, and approved by the Secretary of Health and Human Services for use, may not
                  be classified as a controlled substance.
                      (d) Schedule IV:
                      (i) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation containing not more than 1 milligram of difenoxin and not less than 25
                  micrograms of atropine sulfate per dosage unit, or any salts of any of them;
                      (ii) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of the following substances, including its salts,
                  isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible
                  within the specific chemical designation:
                      (A) Alprazolam;
                      (B) Barbital;
                      (C) Bromazepam;
                      (D) Butorphanol;
                      (E) Camazepam;
                      (F) Chloral betaine;
                      (G) Chloral hydrate;
                      (H) Chlordiazepoxide;

- 15 -


                      (I) Clobazam;
                      (J) Clonazepam;
                      (K) Clorazepate;
                      (L) Clotiazepam;
                      (M) Cloxazolam;
                      (N) Delorazepam;
                      (O) Diazepam;
                      (P) Estazolam;
                      (Q) Ethchlorvynol;
                      (R) Ethinamate;
                      (S) Ethyl loflazepate;
                      (T) Fludiazepam;
                      (U) Flunitrazepam;
                      (V) Flurazepam;
                      (W) Halazepam;
                      (X) Haloxazolam;
                      (Y) Ketazolam;
                      (Z) Loprazolam;
                      (AA) Lorazepam;
                      (BB) Lormetazepam;
                      (CC) Mebutamate;
                      (DD) Medazepam;
                      (EE) Meprobamate;
                      (FF) Methohexital;
                      (GG) Methylphenobarbital (mephobarbital);
                      (HH) Midazolam;
                      (II) Nimetazepam;
                      (JJ) Nitrazepam;

- 16 -


                      (KK) Nordiazepam;
                      (LL) Oxazepam;
                      (MM) Oxazolam;
                      (NN) Paraldehyde;
                      (OO) Pentazocine;
                      (PP) Petrichloral;
                      (QQ) Phenobarbital;
                      (RR) Pinazepam;
                      (SS) Prazepam;
                      (TT) Quazepam;
                      (UU) Temazepam;
                      (VV) Tetrazepam;
                      (WW) Triazolam; [and]
                      (XX) Zaleplon; and
                      [(XX)] (YY) Zolpidem.
                      (iii) Any material, compound, mixture, or preparation of fenfluramine which contains any
                  quantity of the following substances, including its salts, isomers whether optical, position, or
                  geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is
                  possible.
                      (iv) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of the following substances having a stimulant
                  effect on the central nervous system, including its salts, isomers whether optical, position, or
                  geometric isomers, and salts of the isomers when the existence of the salts, isomers, and salts of
                  isomers is possible within the specific chemical designation:
                      (A) Cathine ((+)-norpseudoephedrine);
                      (B) Diethylpropion;
                      (C) Fencamfamine;
                      (D) Fenproprex;

- 17 -


                      (E) Mazindol;
                      (F) Mefenorex;
                      (G) Modafinil;
                      [(G)] (H) Pemoline, including organometallic complexes and chelates thereof;
                      [(H)] (I) Phentermine;
                      [(I)] (J) Pipradrol; [and]
                      (K) Sibutramine; and
                      [(J)] (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
                      (v) Unless specifically excepted or unless listed in another schedule, any material, compound,
                  mixture, or preparation which contains any quantity of dextropropoxyphene
                  (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
                      (e) Schedule V: Any compound, mixture, or preparation containing any of the following
                  limited quantities of narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid,
                  which includes one or more non-narcotic active medicinal ingredients in sufficient proportion to
                  confer upon the compound, mixture, or preparation valuable medicinal qualities other than those
                  possessed by the narcotic drug alone:
                      (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
                      (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
                      (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
                      (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
                  atropine sulfate per dosage unit;
                      (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
                      (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine
                  sulfate per dosage unit;
                      (vii) unless specifically exempted or excluded or unless listed in another schedule, any
                  material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant effect
                  on the central nervous system, including its salts, isomers, and salts of isomers; and
                      (viii) unless specifically excepted or unless listed in another schedule, any material,

- 18 -


                  compound, mixture, or preparation containing any Buprenorphine and its salts.
                      Section 2. Informational note.
                      The symbols used in this bill do not appear in the electronic version. Please refer to the hard
                  copy version on file with the Utah House of Representatives or the Office of Legislative Printing to
                  view these symbols.
                      Section 3. Effective date.
                      If approved by two-thirds of all the members elected to each house, this act takes effect upon
                  approval by the governor, or the day following the constitutional time limit of Utah Constitution
                  Article VII, Section 8, without the governor's signature, or in the case of a veto, the date of veto
                  override.

- 19 -


[Bill Documents][Bills Directory]